3. Summary
Global Markets Direct’s, Congestive Heart Failure (Heart Failure) - Pipeline
Review, H2 2012, provides an overview of the indication’s therapeutic pipeline.
This report provides information on the therapeutic development for
Congestive Heart Failure (Heart Failure), complete with latest updates, and
special features on late-stage and discontinued projects. It also reviews key
players involved in the therapeutic development for Congestive Heart Failure
(Heart Failure). Congestive Heart Failure (Heart Failure) - Pipeline Review, Half
Year is built using data and information sourced from Global Markets Direct’s
proprietary databases, Company/University websites, SEC filings, investor
presentations and featured press releases from company/university sites and
industry-specific third party sources, put together by Global Markets Direct’s
team.
Note*: Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.
4. Scope
- A snapshot of the global therapeutic scenario for Congestive Heart Failure (Heart
Failure).
- A review of the Congestive Heart Failure (Heart Failure) products under
development by companies and universities/research institutes based on
information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from
discovery till registration stages.
Reasons to buy
- Identify and understand important and diverse types of therapeutics under
development for Congestive Heart Failure (Heart Failure).
- Identify emerging players with potentially strong product portfolio and design
effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most
promising pipeline.
5. Table of Contents :
List of Figures 9
Introduction 10
Global Markets Direct Report Coverage 10
Congestive Heart Failure (Heart Failure) Overview 11
Therapeutics Development 12
An Overview of Pipeline Products for Congestive Heart Failure (Heart
Failure) 12
Congestive Heart Failure (Heart Failure) Therapeutics under Development by
Companies 14
Congestive Heart Failure (Heart Failure) Therapeutics under Investigation by
Universities/Institutes 19
Late Stage Products 23
Comparative Analysis 23
Mid Clinical Stage Products 24
Comparative Analysis 24
Early Clinical Stage Products 25
Comparative Analysis 25
Discovery and Pre-Clinical Stage Products 26
Comparative Analysis 26…………….
6. Please follow link if you want More Related
Reports :
Pipeline Review, H2 2012
http://www.aarkstore.com/search/viewresults.asp?searc
h=Pipeline Review, H2 2012&PubId=&pagenum=1